-Contains the highest concentration of C3S on the market (36%)(1)
-High purity tricalcium silicate ensures favorable tissue response and triggers hydroxyapatite formation.
-High pH creates an alkaline environment that helps limit bacterial growth.
-No shrinkage thanks to its resin‑free formulation.
-Offers a hermetic seal with excellent adhesion to dentin and gutta‑percha.
-High flowability (32.2 mm) allows it to penetrate accessory canals without compaction.
-91% clinical success after 2 years in a multicentric randomized controlled trial.
-No postoperative pain reported by day 7.
-Ready‑to‑use syringe with consistent viscosity – no preparation time.
-21G bendable tip for direct intra‑canal delivery that adapts to all anatomies and helps limit overfilling.
-Easy extrusion with just 31N of force for comfortable handling.
-Retreatable in less than 10 minutes with NiTi files
-Works with both cold and warm techniques.
-Obturation with cold technique is as successful as with warm techniques(3)
BioRoot® Flow: is a medical device intended for permanent root canal filling material in combination with gutta-percha points in case of inflamed or necrotic pulp or following a retreatment procedure. Manufactured by Septodont, France. CE marked (CE 2797) Class III implantable.
Internal RD Data – 36% C3S, highest concentration on the market: comparison across ready-to-use syringe endodontic sealers.
91% clinical success: Loose criteria evaluation (Clinicaltrials.gov). Strict criteria evaluation at 24 months post-treatment, the overall success rate was 86.6% in the BioRoot™ Flow group and 87.7% in the BioRoot™ RCS group (non-inferiority demonstrated; p = .0195) (Simon S and Al. Clinical efficacy of root canal treatment at 2 years using a new ready-to- use injectable calcium silicate-based sealer: A multicentric randomised controlled trial. Int Endod J. 2025;00:1–1)
Internal document. C. Wang, N. Mosahebi, J. Camilleri (2021). Testing of a new premixed BioRoot™ RCS (Septodont) / P19/28
Sign up now and get an exclusive access to: